Statistical methods for characterizing molecular mechanisms of human tissue development and disease

Active Cooperative Agreement Awarded Last action

Award ID
U01HG013843
Recipient
Awarding agency
Obligated
$784,000

Award facts

Completion date 71% complete
Funding agency
National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services
Place of performance
New York, NY 10013, USA

Award details come from USAspending.gov.

About this award

This Cooperative Agreement award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $784,000 to the New York Genome Center, Inc. (Nygc) to develop statistical methods and analytical approaches for extracting insights into human and non-human primate tissue development and disease from the Developmental GTEx (dGTEx) project's multi-modal, multi-tissue data.

The key products and services to be delivered under this 3-year award include: 1) methods to analyze transcriptome variation across the human lifespan, including changes in gene expression, alternative splicing, and cell type composition; 2) models to capture changes in gene regulatory networks during development using the dGTEx histology images and spatial transcriptomics data; and 3) mapping and characterization of genetic regulatory variation in dGTEx, with predictive models for improved identification of regulatory variants in pediatric tissues. Nygc will collaborate with sub-awardees at the Barcelona Supercomputing Center, Centre for Genomic Regulation, Johns Hopkins University, and University of Chicago on aspects of the statistical methods development and analysis.

Description

Abstract
The unique biospecimens and data from the developmental gtex (dgtex) project create an exciting opportunity and need for novel methods development. In this project, we propose to develop a set of statistical methods and analytical approaches that are designed to extract insights into human and non-human primate development from the multi-modal and multi-tissue data from dgtex post-mortem donors. Analysis of the dgtex data requires statistical models that can take advantage of the rich structure and diversity of the data across ages and modalities, while addressing some of the inherent challenges. Models explicitly informed by age can capture developmental trajectories of gene regulation, genetic effects, and tissue structure. The range of data modalities also creates an opportunity for novel methods to capture additional effects and improved resolution at the cell-type, isoform, and structural levels. However, these data are also inherently complex, representing a mixture of cell types along with biological and technical noise. The ambitious study design of dgtex also comes with challenges of donor recruitment that limit sample size. The methods proposed here are designed to leverage the benefits of temporal multi-modal data, while addressing data complexity and limited sample size. In our first aim, we will analyze transcriptome variation across the human lifespan, with improved transcript annotation and new methods to characterize how gene expression, alternative splicing and cell type composition change during development and how they contribute in driving phenotypic change. Secondly, we will use multi-modal data from gtex to capture changes in gene regulatory networks during development. From the dgtex histology images and spatial transcriptomics data we will model developmental trajectories of tissue structures, and describe their molecular characteristics as well as role in disease. In our third aim we will map and characterize genetic regulatory variation in dgtex and apply predictive models for improved predictions of regulatory variants in pediatric tissues. In addition to empowering biological discovery, this work has the potential to uncover disease risk factors and mechanisms that originate or manifest during early life.

Transactions

Action Obligated Date
Amendment $0
Amendment $392,000
Original award $392,000

Subawards

Subrecipient Amount Awarded
The University Of Chicago Dr. Im and her postdoctoral scholar will develop methods to investigate transcriptome variation across the human lifespan, integrate the information with deep… $266,796
The Johns Hopkins University As part of this project, Dr. Alexis Battle’s laboratory at Johns Hopkins University will be responsible for leading statistical analysis for rare genetic… $266,247
Fundacio Centre De Regulacio Genomica The group at the CRG will work on the development of methods for causal inference in pseudo- cronological time series, for partitioning the variance in the… $146,785
Barcelona Supercomputing Center The group at the BSC will work on the development of new statistical methods to better estimate dynamic changes in gene expression, alternative splicing, and… $176,346

Quick answers

Who received award U01HG013843?

U01HG013843 was awarded to New York Genome Center, Inc. by National Human Genome Research Institute (National Institutes of Health) on September 24, 2024.

How much is award U01HG013843 worth?

$784,000 has been obligated on U01HG013843.

Which agency awarded U01HG013843?

National Human Genome Research Institute (National Institutes of Health) awarded U01HG013843, with funding from National Institute of Child Health and Human Development (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award